02 15-14 fujifilm results-q1

17
1 Earnings of FY2014/3 3Q FORWARD-LOOKING STATEMENTS Forward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are management’s current assumptions and beliefs based on currently available information. Such forward-looking statements are subject to a number of risks, uncertainties, and other factors. Accordingly, actual results may differ materially from those projected due to various factors. Jan. 30, 2014 To Celebrate the Group’s 80 th Anniversary 2 To Celebrate the Group To Celebrate the Group’ s 80 s 80 th th Anniversary Anniversary Reviewing the past 80 years Reviewing the past 80 years Photographic Photographic Technologies Technologies Adjusting to the change in society, Fujifilm expanded its business field by utilizing photographic technologies. Information Information Imaging Imaging Document Document

Upload: audiologiks

Post on 19-Jun-2015

29 views

Category:

Business


1 download

TRANSCRIPT

Page 1: 02 15-14 fujifilm results-q1

1

Earnings of FY2014/3 3Q

FORWARD-LOOKING STATEMENTSForward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are management’s current assumptions and beliefs based on currently available information. Such forward-looking statements are subject to a number of risks, uncertainties, and other factors. Accordingly, actual results may differ materially from those projected due to various factors.

Jan. 30, 2014

To Celebrate the Group’s 80th Anniversary

2

To Celebrate the GroupTo Celebrate the Group’’s 80s 80thth AnniversaryAnniversary

Reviewing the past 80 yearsReviewing the past 80 years

PhotographicPhotographicTechnologiesTechnologies

Adjusting to the change in society, Fujifilm expanded its business field by utilizing photographic technologies.

InformationInformation

ImagingImaging DocumentDocument

Page 2: 02 15-14 fujifilm results-q1

3

For Further GrowthFor Further Growth

Three pillars that realize growthThree pillars that realize growth

Strengthen fundamental capacity of each workplace

Accelerate globalization2

Create new businesses3

To Celebrate the GroupTo Celebrate the Group’’s 80th Anniversarys 80th Anniversary

4

Creation of New BusinessesCreation of New Businesses

A place that createsnew values for a better future with business partners

Highly Functional MaterialsHighly Functional MaterialsBusiness Development HeadquartersBusiness Development Headquarters

Open Innovation HubOpen Innovation Hub

Create new highly functional materials business with a slogan of “small, speedy, less investment, and many”

Speedily fuse needs and seeds by reinforcing cooperation with external partners

Create products and services that offer new values

To Celebrate the GroupTo Celebrate the Group’’s 80th Anniversarys 80th Anniversary

Page 3: 02 15-14 fujifilm results-q1

5

At Fujifilm, we are continuously innovating — creatingnew technologies, products and services that inspire

and excite people everywhere.Our goal is to empower the potential and expand

the horizons of tomorrow’s businesses and lifestyles.

We take an open and flexible attitude to innovation, combining our own original technology with human resources, expertise and technology from around the world.

Through this powerful synergy, we rapidly and nimbly develop new solutions that address the true needs of our global customers.

To Celebrate the GroupTo Celebrate the Group’’s 80th Anniversarys 80th Anniversary

A New Corporate SloganA New Corporate Slogan

Page 4: 02 15-14 fujifilm results-q1

Earnings of FY2014/3 3Q

Jan. 30, 2014

FORWARD-LOOKING STATEMENTSForward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are management’s current assumptions and beliefs based on currently available information. Such forward-looking statements are subject to a number of risks, uncertainties, and other factors. Accordingly, actual results may differ materially from those projected due to various factors.

8

FY2014/3 3Q9 Months

FY2013/3 3Q9 Months

¥99

¥132

¥129.68

62.53.5%

114.26.4%

99.65.6%

1,774.4100.0%

¥80

¥102

¥59.89

28.81.8%

62.83.9%

65.44.1%

1,611.2100.0%

Change

Revenue 163.2+10.1%

Operating Income 34.2+52.4%

Income before Income Taxes

51.4+81.7%

Net Income Attributable to FUJIFILM Holdings

33.7+116.6%

Net Income Attributable to FUJIFILM Holdings per Share ¥69.79

Exchange Rates US$/¥€/¥

+¥19

+¥30

Consolidated Performance for FY2014/3 3QConsolidated Performance for FY2014/3 3Q((Apr. 2013 Apr. 2013 –– Dec. 2013Dec. 2013))

(Billions of yen)(Billions of yen)

Note: Analysis of operating income (YoY) Exchange rate fluctuations: +¥30.1 billion, Raw material prices: ¥(1.5) billion

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

Page 5: 02 15-14 fujifilm results-q1

9

54.5 (+8.8%)671.1616.6Information Solutions

90.0 (+12.2%)825.2735.2Document Solutions

FY2014/3FY2013/3

1,774.4

278.1 18.7 (+7.2%)259.4Imaging Solutions

1,611.2

9 Months

163.2 (+10.1%)Total

ChangeRevenue

FY2014/3Change

9 MonthsOperating Income

FY2013/3

11.1 (+26.2%)53.542.4Information Solutions

18.5 (+35.3%)70.952.4Document Solutions

99.6

(23.3)

(1.5)

2.2 (25.5)Corporate Expenses & Eliminations

2.4 (Reduction of deficit)(3.9)Imaging Solutions

65.4 34.2 (+52.4%)Total

Imaging’12 ‘13 ’12 ‘13 ’12 ‘13

Consolidated Revenue and Operating Income by SegmentsConsolidated Revenue and Operating Income by Segments

(Billions of yen)(Billions of yen)

(Billions of yen)(Billions of yen)Note: After elimination of intersegment transaction.

(Billions of yen)(Billions of yen)

Revenue(9 Months)

Information Document

’12 ‘13 ’12 ‘13 ’12 ‘13

(Billions of yen)(Billions of yen)

Imaging Information Document

Operating income[Operating margin]

(9 Months)

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

200

600

400

800

259.4278.1

616.6671.1

735.2825.2

0

0

20

80

60

40

(3.9)

42.4

(1.5)

53.5

[-1.5%] [-0.5%]

52.4

70.9

[6.9%]

[8.0%] [7.1%]

[8.5%]

10

Summary by Operating Segment of 3QSummary by Operating Segment of 3Q

Imaging SolutionsImaging Solutions

Strong sales for instant cameras were seen in the photo imaging business. In addition, such high-value-added products as Year Album expanded and overall sales rose.

In the electronic imaging field, sales decreased due to the continuous worldwide decline in overall demand for compact digital cameras. Sales of such high-end models as the X-series proceeded smoothly.

Robust sales were seen in the optical devices field, owing to the large sales increase in camera modules for smartphones as well as strong sales of TV camera lenses and projector lenses.

Revenue and profitability improved, Revenue and profitability improved, reflecting such factors as the strong sales in the photoreflecting such factors as the strong sales in the photo

imaging business, the falling yen exchange rate, imaging business, the falling yen exchange rate, and cost reductions.and cost reductions.

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

18.7 (+7.2%)

YoY

278.1

Revenue YoYOperating income

2.4 (Reduction of deficit)(1.5)

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

(Billions of yen)(Billions of yen)

Page 6: 02 15-14 fujifilm results-q1

11

Information SolutionsInformation SolutionsIn the medical systems business, strong sales were seen in such growth fields as medical-use picture archiving and communications systems and endoscopes, and overall sales increased.As for the pharmaceuticals business, sales grew, reflecting strong sales in Toyama Chemical and FUJIFILM Pharma.Sales in overall healthcare field greatly increased.

In the FPD materials business, sales of WV film declined, reflecting the impact of weak demand for IT equipment. On the other hand, strong TV sales led sales of VA film and IPS film to proceed smoothly.

Sales grew immensely in the graphic systems business, owing to the strong sales of CTP plates as well as the positive impact of the falling yen exchange rate.

Regarding the industrial products business, sales of sensor film for touch panels EXCLEARproceeded smoothly.In addition, sales increased in the electronic materials and recording media business.

Both revenue and profit rose, owing to strong sales in Both revenue and profit rose, owing to strong sales in such fields as healthcare and the positive impact of the such fields as healthcare and the positive impact of the

exchange rate fluctuation.exchange rate fluctuation.

11.1 (+26.2%)53.554.5 (+8.8%)671.1

YoYRevenue YoYOperating income

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

Summary by Operating Segment of 3QSummary by Operating Segment of 3Q(Billions of yen)(Billions of yen)

12

• Sales in Japan and the Asia-Oceania region as well as shipments for Xerox Corporation increased.

• As for the office products business, sales volume of color products increased in all regions. In addition, sales volume of monochrome products rose in the Asia-Oceania region.

• In the office printers business, strong sales were seen for color products in the Asia-Oceania region, and overall sales volume increased.

• Regarding the production services business, sales of color on-demand publishing systems increased in Japan and the Asia-Oceania region, and the shipment volume for Xerox Corporation also increased leading to an increase in overall sales volume.

• Sales grew in the global services business in both Japan and the Asia-Oceania region.

• In addition to the rise in revenue, improvement in manufacturing costs and expenses contributed to the increase in profit.

Document SolutionsDocument Solutions

Strong sales were seen in each region, Strong sales were seen in each region, and both revenue and profit increased.and both revenue and profit increased.

90.0 (+12.2%)

YoY

825.2

Revenue YoYOperating income

18.5 (+35.3%)70.9

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

Summary by Operating Segment of 3QSummary by Operating Segment of 3Q(Billions of yen)(Billions of yen)

Page 7: 02 15-14 fujifilm results-q1

13

3,241.3

1,507.0

540.5

425.4

541.1

1,734.3

155.0

427.7

595.9

555.7

Dec. 13

3,059.6

1,498.3

540.0

412.2

546.1

1,561.3

127.1

399.9

588.9

445.4

Mar. 13

3,120.3

1,488.0

536.1

415.2

536.7

1,632.3

149.3

403.2

564.9

514.9

Sep. 13Change from

Mar. 13

Cash and cash equivalents 110.3

Notes and accounts receivable

7.0

Inventories 27.8

Marketable securities and other

27.9

Total current assets 173.0

Property, plant and equipment (5.0)

Goodwill, net 13.2

Investment securities and other

0.5

Total noncurrent assets 8.7

Total assets 181.7

3,241.3

2,197.3

169.7

2,027.6

1,044.0

418.6

245.7

379.7

Dec. 13

3,059.6

2,024.8

155.9

1,868.9

1,034.8

425.5

251.0

358.3

Mar. 13 Sep. 13Change from

Mar. 13

Short-term and long-term debt 372.3 21.4

Notes and accounts payable

234.5 (5.3)

Other liabilities 416.2 (6.9)

Total liabilities 1,023.0 9.2

Total FUJIFILM Holdings shareholders' equity

1,934.6 158.7

Noncontrollinginterests 162.7 13.8

Total equity 2,097.3 172.5

Total liabilities and equity 3,120.3 181.7

145

105

Dec. 13

132

98

Sep. 13

+¥24

+¥11

Change from Mar. 13

121

94

Mar. 13Exchange Rates

US$/¥

€/¥

Consolidated Balance SheetConsolidated Balance Sheet(Billions of yen)(Billions of yen)

(yen)(yen)

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

14

11年度上期 12年度上期 13年度上期 (6.1)

(125.1)

(54.5)

9.5

(13.2)

(66.9)

119.0

16.6

(30.7)

(30.8)

(17.8)

38.5

102.6

40.6

FY2013/3

9 Months

(16.6)(14.3)Purchases of software

(94.4)(87.1)C/F from investing activities

92.8(18.0)Free cash flows

(18.0)(20.8)Others

(2.4)22.2Sales and purchases of marketable and investment securities

(57.4)(74.2)Capital expenditure

187.269.1C/F from operating activities

1.825.4Others

(8.4)(25.2)Change in accrued income taxes

and other liabilities

(12.3)(18.3)Change in notes and accounts payable-trade

(0.1)(38.4)Change in inventories

24.4(16.0)Change in notes and accounts receivable

104.3107.9Depreciation & amortization

77.533.7Net income

FY2014/3

9 Months

FY2012/3

9 Months

(5.1) 52.1 129.8C/F from operating activities + Capital expenditure

C/F from operating activities

C/F from investing activities

Free cash flows

Cash FlowsCash Flows(Billions of yen)(Billions of yen)

FY2012/3 FY2013/3 FY2014/3

Cash Flows (9 Months)(Billions of yen)(Billions of yen)

90

60

30

0

180

210

Performance Summary of FY2014/3 3Q (9 Months)Performance Summary of FY2014/3 3Q (9 Months)

69.1

119.0

87.1

125.1

(18.0)(6.1)

187.2

94.492.8

150

120

(30)

Page 8: 02 15-14 fujifilm results-q1

15

(Billions of yen)(Billions of yen)

Note: Impact of exchange rate movements on operating income (FY2014/3 full year, ¥1 change) US$/¥: ¥1.1 billion €/¥: ¥0.9 billion

Consolidated Financial Forecast for FY2014/3 Consolidated Financial Forecast for FY2014/3 (as of Jan. 30, 2014)(as of Jan. 30, 2014)

Forecast for FY2014/3Forecast for FY2014/3

Note: Exchange rates for 4Q are US/¥: ¥103, €/¥: ¥140

¥100¥134

¥166.01

80.03.3%

155.06.5%

140.05.8%

2,400.0100.0%

FY2014/3(Latest)

¥97¥127

¥145.27

70.03.0%

140.06.0%

140.06.0%

2,350.0100.0%

FY2014/3(Previous

announcement)

+¥3+¥7

¥20.74

10.0+14.3%

15.0+10.7%

50.0+2.1%

Change from previous

announcement

+¥17+¥27

¥53.36

25.7+47.4%

35.8+30.0%

25.9+22.7%

185.3+8.4%

Change from previous yearFY2013/3

¥83¥107

¥112.65

54.32.5%

119.25.4%

114.15.2%

2,214.7100.0%

Revenue

Operating Income

Income before Income Taxes

Net Income Attributable to FUJIFILM Holdings

Net Income Attributable to FUJIFILM Holdingsper Share

Exchange Rates US$/¥€/¥

Corporate Communication Office, Corporate Planning Div.

http://www.fujifilmholdings.com/en/index.html

At Fujifilm, we are continuously innovating — creatingnew technologies, products and services that inspire

and excite people everywhere.Our goal is to empower the potential and expand

the horizons of tomorrow’s businesses and lifestyles.

Page 9: 02 15-14 fujifilm results-q1

17

Earnings for FY2014/3 3Q

AppendixAppendix

18

Earnings for FY2014/3 3Q Earnings for FY2014/3 3Q 3 Months/9 Months3 Months/9 Months

ChangeFY2014/3FY2013/3ChangeFY2014/3FY2013/3

+¥20

+¥32

12.7+68.9%

21.9+73.1%

19.1+82.9%

50.5+9.2%

¥101

¥137

31.05.2%

51.78.6%

42.27.0%

600.1100.0%

¥81

¥105

18.33.3%

29.85.4%

23.14.2%

549.6100.0%

3 Months 9 Months

¥99

¥132

62.53.5%

114.26.4%

99.65.6%

1,774.4100.0%

¥80

¥102

28.81.8%

62.83.9%

65.44.1%

1,611.2100.0%

Revenue163.2+10.1%

Operating Income

34.2+52.4%

Income before Income Taxes

51.4+81.7%

Net Income Attributable to FUJIFILM Holdings

33.7+116.6%

Exchange Rates US$/¥€/¥

+¥19

+¥30

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Note: Analysis of operating income (9 months, YoY) Exchange rate fluctuations: +¥30.1 billion, Raw material prices: ¥(1.5) billion

(Billions of yen)(Billions of yen)

Page 10: 02 15-14 fujifilm results-q1

19

(Billions of yen)(Billions of yen)

(Billions of yen)(Billions of yen)Note: After elimination of intersegment transaction.

Change

50.5 (+9.2%)

30.1 (+12.3%)

11.4 (+5.4%)

9.0 (+9.7%)

Change

54.5 (+8.8%)671.1616.6223.2211.8Information Solutions

90.0 (+12.2%)825.2735.2275.2245.1Document Solutions

FY2014/3FY2014/3 FY2013/3FY2013/3

1,774.4

278.1

600.1

101.7 18.7 (+7.2%)259.492.7Imaging Solutions

1,611.2

9 Months

163.2 (+10.1%)549.6Total

3 MonthsRevenue

Change

19.1 (+82.9%)

0.6

8.5 (+52.7%)

3.8 (+21.0%)

6.2 (Return to profitability)

Change FY2014/3FY2014/3

9 Months3 MonthsOperating Income

[Operating Margin] FY2013/3FY2013/3

11.1 (+26.2%)53.5

[8.0%]

42.4

[6.9%]

21.7

[9.7%]

17.9

[8.4%]Information Solutions

18.5 (+35.3%)70.9

[8.5%]

52.4

[7.1%]

24.7

[8.9%]

16.2

[6.6%]Document Solutions

99.6

[5.6%]

(23.3)

(1.5)

[-0.5%]

42.2

[7.0%]

(8.1)

3.9

[3.8%]

2.2 (25.5)(8.7)Corporate Expenses &

Eliminations

2.4 (Reduction of deficit)(3.9)

[-1.5%]

(2.3)

[-2.5%]Imaging Solutions

65.4

[4.1%]34.2 (+52.4%)

23.1

[4.2%]Total

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Earnings for FY2014/3 3Q Earnings for FY2014/3 3Q 3 Months/9 Months3 Months/9 Months

20

FY2014/3 3Q (3 Months) Performance by Operating SegmentFY2014/3 3Q (3 Months) Performance by Operating Segment

Imaging SolutionsImaging Solutions

Information SolutionsInformation Solutions

Document SolutionsDocument Solutions

Strong sales were seen for instant cameras and postcards, leading to an increase in overall sales in the photo imaging business.

Strong sales were seen for the premium interchangeable lens camera FUJIFILM X-E2. Fujifilm further expanded its lineup of high-end models.

As for the optical devices field, robust sales continued in camera modules for smartphones.

Sales proceeded smoothly in the medical systems and pharmaceuticals businesses. As for the life sciences business, strong sales were seen for the new whitening skincare series ASTALIFT WHITE.

In the FPD materials business, sales of FUJITAC and VA film were below the Company’s expectations, due to inventory adjustment seen at some manufacturers. However, sales of WV film were above the Company’s expectations.

As for the graphic systems business, Fujifilm and Heidelberger have unveiled a strategic partnership in the area of inkjet printing.

Sales increased in Japan and elsewhere in the Asia-Oceania region, as well as shipments for Xerox Corporation.

The rise in gross operating profit, due to sales growth, as well as the improvement in both manufacturing costs and expenses contributed to the increase in operating income.

In November 2013, Fuji Xerox began operation of a new manufacturing company (Fuji Xerox Hai Phong) in Vietnam.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Page 11: 02 15-14 fujifilm results-q1

21

Imaging SolutionsImaging Solutions(Billions of yen)(Billions of yen)

(Billions of yen)(Billions of yen)Note: After elimination of intersegment transaction.

9 Months3 Months

9.0 (+9.7%)

(0.4) (-1.1%)

3.3 (+25.9%)

(3.7) (-14.2%)

9.4 (+17.5%)

Change

101.7

38.6

16.1

22.5

63.1

FY2014/3

92.7

39.0

12.8

26.2

53.7

FY2013/3

(9.9) (-13.6%)63.072.9Electronic Imaging

14.8 (+40.0%)51.736.9Optical Devices

4.9 (+4.4%)114.7109.8Optical Device &

Electronic Imaging Products

13.8 (+9.2%)163.4149.6Photo Imaging

278.1

FY2014/3

18.7 (+7.2%)259.4Total

FY2013/3 ChangeRevenue

9 Months3 Months

6.2 (Return to profitability)

Change

3.9[3.8%]

FY2014/3

(2.3)[-2.5%]

FY2013/3

(1.5)[-0.5%]

FY2014/3

2.4 (Reduction of deficit)(3.9)

[-1.5%]Imaging Solutions

FY2013/3 Change

Operating Income

[Operating Margin]

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Earnings for FY2014/3 3Q Earnings for FY2014/3 3Q 3 Months/9 Months3 Months/9 Months

22

12.8 14.3 16.9 18.7 16.1

19.120.6 22.5

53.7

53.2 48.551.8

63.1

19.926.2

-20

0

20

40

60

80

100

-5

0

5

10

15

20

25

Change in Quarterly Earnings by Operating Segment Change in Quarterly Earnings by Operating Segment

Imaging SolutionsImaging Solutions

Note: After elimination of intersegment transaction.

(Billions of yen)(Billions of yen)

Revenue

86.092.7

86.6

-0.9(-1.1%)

-2.3(-2.5%)

3.1(3.6%)

80

40

0

20

10

0

FY2014/3 2Q FY2014/3 3QFY2013/3 3Q FY2013/3 4Q FY2014/3 1Q

Photo Imaging

ElectronicImaging

Operating Income for Imaging Solutions(Operating Margin)

Optical Devices

Optical Device & Electronic Imaging

Products

Operating Income

90.4

-4.5(-4.9%)

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

101.7

3.9(3.8%)

Page 12: 02 15-14 fujifilm results-q1

23

Information SolutionsInformation Solutions (Billions of yen)(Billions of yen)

(Billions of yen)(Billions of yen)Note: After elimination of intersegment transaction.

Note: Due to a partly business transfer between the Graphic Systems and the Industrial Products businesses, some numbers have been changed.

9 Months3 Months

3.8 (+21.0%)

Change

21.7[9.7%]

FY2014/3

17.9[8.4%]

FY2013/3

53.5[8.0%]

FY2014/3

11.1 (+26.2%)42.4[6.9%]

Information Solutions

FY2013/3 Change

Operating Income[Operating Margin]

27.1 (+15.3%)204.3177.28.3 (+13.8%)68.760.4Graphic Systems

(10.0) (-8.4%)109.0119.0(10.4) (-23.6%)33.844.2FPD Materials

3.6 (+12.0%)33.129.50.9 (+8.0%)11.210.3Recording Media

Change

11.4 (+5.4%)

4.0 (+23.0%)

8.6 (+10.9%)

Change

3.6 (+5.9%)64.961.321.617.6Industrial Products

Electronic Materials & Others

FY2014/3FY2014/3 FY2013/3FY2013/3

671.1

259.8

223.2

87.9 30.2 (+13.2%)229.679.3Healthcare

616.6

9 Months

54.5 (+8.8%)211.8Total

3 MonthsRevenue

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Earnings for FY2014/3 3Q Earnings for FY2014/3 3Q 3 Months/9 Months3 Months/9 Months

24

20.2 20.8 21.610.3 13.0 10.9 11.2

44.2 34.5 40.0 35.2 33.8

60.4 64.5 66.0 69.6 68.7

79.387.9

22.517.6

11.0

92.279.7

107.7

0

40

80

120

160

200

240

280

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

Healthcare

Graphic Systems

Information SolutionsInformation SolutionsOperating Income

(Billions of yen)(Billions of yen)

Note: After elimination of intersegment transaction.

Change in Quarterly Earnings by Operating Segment Change in Quarterly Earnings by Operating Segment

211.8

239.9

217.4

17.9(8.4%)

30.5(12.7%)

10

0

20

30240

160

80

0

Revenue

11.5(5.3%)

FPD Materials

Recording Media

Industrial ProductsElectronic Materials & Others

Operating Income for Information Solutions(Operating Margin)

Note: Due to a partly business transfer between the Graphic Systems and the Industrial Products businesses, some numbers have been changed.

FY2014/3 2Q FY2014/3 3QFY2013/3 3Q FY2013/3 4Q FY2014/3 1Q

230.5

20.3(8.8%)

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

223.2

21.7(9.7%)

Page 13: 02 15-14 fujifilm results-q1

25

Document SolutionsDocument Solutions

Note: After elimination of intersegment transaction.

(Billions of yen)(Billions of yen)

(Billions of yen)(Billions of yen)

17.7 (+15.3%)133.3115.69.1 (+24.6%)45.836.7Office Printers

7.2 (+6.8%)112.8105.63.4 (+9.9%)37.634.2Production Services

26.8 (+32.4%)109.582.74.1 (+12.8%)36.031.9Global Services

Change

30.1 (+12.3%)

6.9 (+30.9%)

6.6 (+5.5%)

Change

20.1 (+30.6%)86.065.929.923.0Others

FY2014/3FY2014/3 FY2013/3FY2013/3

825.2

383.6

275.2

125.9 18.2 (+5.0%)365.4119.3Office Products

735.2

9 Months

90.0 (+12.2%)245.1Total

3 MonthsRevenue

9 Months3 Months

8.5 (+52.7%)

Change

24.7[8.9%]

FY2014/3

16.2[6.6%]

FY2013/3

70.9[8.5%]

FY2014/3

18.5 (+35.3%)52.4[7.1%]

Document Solutions

FY2013/3 Change

Operating Income

[Operating Margin]

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Earnings for FY2014/3 3Q Earnings for FY2014/3 3Q 3 Months/9 Months3 Months/9 Months

26

31.9 33.936.0

42.835.9

39.3 37.6

36.7

42.9

42.2

45.4 45.8

39.639.6

34.2

125.9

127.7

123.6

130.0

119.3

0

5

10

15

20

25

30

Office Products

Office Printers

Production Services

Global Services

Document SolutionsDocument Solutions(Billions of yen)(Billions of yen)

Operating Income for Document Solutions(Operating Margin)

Revenue Operating Income

Note: After elimination of intersegment transaction.

Change in Quarterly Earnings by Operating Segment Change in Quarterly Earnings by Operating Segment

16.2(6.6%)

245.1

277.0

23.5(8.4%)

21.7(8.1%)

265.3

0

300

200

100

30

20

10

0FY2014/3 2Q FY2014/3 3QFY2013/3 3Q FY2013/3 4Q FY2014/3 1Q

24.5(8.5%)

284.7

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

24.7(8.9%)

275.2

Page 14: 02 15-14 fujifilm results-q1

27

Revenue from Domestic and OverseasRevenue from Domestic and Overseas(Billions of yen)(Billions of yen)

FY2014/3 9 MonthsFY2013/3 9 Months

100.0%

58.7%

28.2%

11.0%

12.0%

18.5%

41.3%

Ratio (%)

163.2 (+10.1%)1,774.41,611.2100.0%Consolidated total

156.6 (+17.7%)1,042.2885.655.0%Overseas

89.8 (+21.9%)499.9410.125.5%Asia and others

47.6 (+32.3%)195.1147.59.2%China

27.9 (+15.0%)213.9186.011.5%Europe

38.9 (+13.4%)328.4289.518.0%The Americas

6.6 (+0.9%)732.2725.645.0%Domestic

ChangeRatio (%)

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

28

Capital ExpenditureCapital Expenditure , Depreciation & Amortization, Depreciation & Amortization

*Note: Figures do not include amounts for rental equipment handled by the Document Solutions segment.

(Billions of yen)(Billions of yen)

Imaging Solutions

Document Solutions Corporate

Information Solutions

Depreciation & Amortization (9 Months)

Capital Expenditure (9 Months)

FY2012/3 FY2013/3

FY2012/3 FY2013/3

FY2014/3

FY2014/3

Full year9 Months3 Months

93.4

141.5

13.3

71.8

53.1

3.3

76.7

9.9

39.9

24.8

2.1

FY

2013/3

66.5

102.6

8.9

51.7

39.4

2.6

53.1

7.1

30.8

13.8

1.4

FY

2013/3

23.5

35.7

3.5

17.0

14.1

1.1

15.7

2.2

7.5

5.5

0.5

FY

2013/3

96.6

147.8

14.6

72.5

57.5

3.2

90.9

12.8

56.2

19.3

2.6

FY

2012/3

90.0

140.0

-

-

-

-

80.0

-

-

-

-

FY2014/3

(forecast)

22.8

36.3

3.4

17.6

14.4

0.9

21.3

2.0

7.7

11.3

0.3

FY

2014/3

24.3

37.5

3.4

17.9

15.4

0.8

17.6

3.1

10.3

3.6

0.6

FY

2012/3

65.3

104.3

9.4

50.8

41.7

2.4

49.4

7.5

21.8

19.0

1.1

FY

2014/3

69.5

107.9

9.9

52.3

43.3

2.4

63.2

8.6

41.5

11.1

2.0

FY

2012/3

Imaging

Information

Document

Corporate

Imaging

Information

Document

Corporate

Depreciation*

Depreciation&

Amortization

Capex *

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

63.28.6

11.1

53.1

30.8

13.8

21.8

19.0

41.5

7.149.4

7.5

9.9

52.3

43.3

107.9 102.68.9

51.7

39.4

104.39.4

50.8

41.7

Page 15: 02 15-14 fujifilm results-q1

29

Imaging Solutions

Document Solutions

Corporate

Information Solutions

R&D Expenses, SG&A ExpensesR&D Expenses, SG&A Expenses

(Billions of yen)(Billions of yen)

R&D Expenses (9 Months)

FY2013/3 FY2014/3

25.7%

154.0

6.5%

39.2

1.8

15.0

15.7

6.7

FY2014/3

26.4%

145.2

7.5%

41.3

2.5

15.8

16.1

6.9

FY2013/3

3 Months Full year9 Months

-

-

7.1%

170.0

-

-

-

-

FY2014/3

(forecast)

27.0%

434.7

7.6%

123.1

8.2

48.3

46.1

20.5

FY2013/3

26.0%

459.9

6.9%

122.7

5.9

49.7

47.4

19.7

FY2014/3

7.6%<ratio to revenue>

10.5

67.5

63.4

26.8

Imaging

Information

Document

Corporate

25.6%

568.2

168.2

FY2013/3

<ratio to revenue >

SG&A Expenses

R&D Expenses

Note: As of FY2014/3 1Q, the Optical Devices business has been transferred from the information solutions segment to the imaging solutions segment, due to a change in the corporate structure, and some numbers have been changed.

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

46.1

48.3

8.2

123.1 122.75.9

49.7

47.4

20.5 19.7

30

Exchange Rates, Raw Material Prices, and Number of EmployeesExchange Rates, Raw Material Prices, and Number of Employees

Exchange RatesExchange Rates

Number of EmployeesNumber of Employees

(yen)(yen)

Impact of exchange rate movements on operating income ( FY2014/3 full year, ¥1 change)US$/¥: ¥1.1 billion €/¥: ¥0.9 billion

81,542

2012 Dec.

80,322

2013 Mar.

79,965

2013 Jun.

79,837

2013 Sep.

80,113

2013 Dec.

Consolidated Total

Raw Material PricesRaw Material Prices (Average) ((¥¥1,000/kg)1,000/kg)

132

99

9 Months

FY2014/3FY2013/3

137

101

3Q

105

81

3Q

129

99

1Q

134

100

Full year (forecast)

131

99

2Q

103

80

1Q

98

79

2Q

102

80

9 Months

122

93

4Q

107

83

Full year

US$/¥

€/¥

72

9 Months

FY2014/3FY2013/3

68

3Q

83

3Q

78

1Q

72

Full year (forecast)

68

2Q

79

1Q

71

2Q

78

9 Months

91

4Q

81

Full year

Silver

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Page 16: 02 15-14 fujifilm results-q1

31

PipelinePipeline

Note: FKB327 (a biosimilar of adalimumab) from FUJIFILM KYOWA KIRIN Biologics, a equity method affiliated company, started P I clinical trials in Europe on April 2013 as planned.

Bio

Bio

Under non-clinical trialU.S.A./Europe/Japan

InjectionAnticancer drug (intractable solid cancer)

FF-10502

Under non-clinical trialU.S.A./Europe/Japan

InjectionAnticancer drug (intractable solid cancer)(armed antibody)

FF-21101

Preparing for PⅠU.S.A.

PⅠJapanOralAnticancer drug (myelodysplastic syndrome)

FF-10501

PⅢJapanInjectionAnticancer drug (prostate cancer)ITK-1

PⅠJapanOralMacrolide antibacterial agentT-4288

Completed PⅠJapan

PⅡU.S.A.OralAlzheimer's disease drugT-817MA

PⅠU.S.A.InjectionAntifungal agentT-2307

Already launched as Geninax in Japan

Completed PⅢ and preparing to submit an application

ChinaOralNew-type quinolone synthetic antibacterial agent

T-3811

PⅢU.S.A.

Submitted an application for permission

JapanOralAntiviral agentT-705

NoteDevelopment stageRegionFormulationTherapeutic categoryDevelopment

code

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

32

AppendixAppendix

・ Business presentation materials- Nov. 2013 Business Presentation for Medical Systems Business- Nov. 2013 Business Presentation for Pharmaceuticals Business

・ Conference Materials- Dec. 2013 NOMURA INVESTMENT FORUM 2013

FUJIFILM Holdings FUJIFILM Holdings -- Investor RelationsInvestor Relationshttp://www.fujifilmholdings.com/en/investors/index.html

What Kind of Company Is Fujifilm?What Kind of Company Is Fujifilm?http://www.fujifilmholdings.com/en/investors/guidance/index.html

IRIR Events MaterialsEvents Materialshttp://www.fujifilmholdings.com/en/investors/ir_events/business_presentations/index.html

FUJIFILM Holdings Annual Report 2013FUJIFILM Holdings Annual Report 2013http://www.fujifilmholdings.com/en/investors/annual_reports/2013/index.html

FY2014/3 3Q AppendixFY2014/3 3Q Appendix

Page 17: 02 15-14 fujifilm results-q1

Corporate Communication Office, Corporate Planning Div.

http://www.fujifilmholdings.com/en/index.html

At Fujifilm, we are continuously innovating — creatingnew technologies, products and services that inspire

and excite people everywhere.Our goal is to empower the potential and expand

the horizons of tomorrow’s businesses and lifestyles.